In case of locomotor diseases of dogs the options for the continuous treatm
ent of chronic inflammation and pain has been limited so far. The non-stero
id anti-inflammatory and analgesic drug, carprofen (Rimadyl, Pfizer) can be
used much more safely than its precedents. In the article the data of 427
dogs treated with carprofen in 104 veterinary surgeries are elaborated. 65%
of veterinary questionnaires were sent back together with the questionnair
es containing the opinion of the owners. 46% of the treated dogs were of la
rge breed and a body weight of 30 kg on average and 8-12 years old. Occurre
nce of males among the patients was double than that of females. 72% of the
patients were treated continuously for a month or longer. 87% of the dogs
had severe or medium degree lameness. 86% of the changes were chronic, 44%
were localised to the hip joint, 21% to the spinal chord, 21% to other join
ts (shoulder, elbow, mandible). On the basis of veterinarians' opinion 76%
of the cases improved well. and significantly, in case of owners' opinion t
his was 79%. In case of 85% of the treated cases improvement started on the
first week The veterinarians treated acute changes (panostitis, luxation)
in 13% of the 427 patients and tumours (bone tumour) in 1% of them. The vet
erinarians observed temporary vomiting as side effect in 2% of the 427 trea
ted cases, temporary diarrhoea in 1.6% and decreased or increased appetite
in 3%. Domestic results support the effectiveness and safety of carprofen f
or the continuous treatment of dogs suffering from chronic locomotor diseas
e and for the improvement their life quality.